Xontogeny is a biotech aggregator with a differentiated business model to support the accelerated development of life science technologies in the pursuit of helping patients with serious diseases. The Company partners with entrepreneurs, providing the leadership and operating experience needed to increase the probability of success with early drug and technology development.
Xontogeny is assembling a senior team of life science professionals with deep experience in drug development to advance a select portfolio of product candidates and technologies in ventures that are focused across a number of serious disease areas from preclinical through clinical proof-of-concept studies.
Latest funding size
Time since last funding
|9 months ago|